Illumina Suit Over Gene Tech Patents Gets The Boot

Law360, New York (December 15, 2010, 2:33 PM EST) -- A federal judge has let genetic research company Affymetrix Inc. off the hook for the alleged infringement of two Illumina Inc. patents covering gene-sequencing technology, finding that the defendant's microarrays failed to meet all elements of the asserted claims.

Judge Barbara B. Crabb of the U.S. District Court for the Western District of Wisconsin granted Affymetrix's motion for summary judgment of noninfringement Tuesday on the grounds that its accused products did not include substrate — or a material that can be modified to contain individual discrete...
To view the full article, register now.